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ABBREVIATIONS  USED
APN   -    Acute   Pyelonephritis
CT      -   Computed   Tomography
DM     -   Diabetes   Mellitus
EPN   -    Emphysematous   Pyelonephritis
PCN   -    Percutaneous   Nephrostomy
PUJ    -    Pelvi Ureteric Junction
USG   -    Ultrasonogram
UTI     -   Urinary   Tract    Infection
VUR  -     Vesico Ureteric  Reflux
WBC  -   White  Blood Cell
XGP   -    Xanthogranulomatous   Pyelonephritis
VUJ    -    Vesico  Ureteric Junction
1INTRODUCTION
            Inflammation  of  renal  parenchyma  and  collecting   system  are
usually secondary  to   microbial  infections . Interstitial   renal  inflammation
caused  predominantly  by  bacterial  infection, is   nowadays   recognized   as  a
non  specific   histopathological    change   that   can   occur  due  to    various
immunologic,  congenital,   or   toxin   induced   lesions   that    develop   in   the
absence    of  bacterial  infection.
              Urinary  Tract   Infection  (UTI )  is  considered  as  an  inflammatory
response  of  the  urothelium  to  microbial    invasion .  UTIs   exist  as  one  of
the   most  prevalent  microbial  diseases  in   the    society  with  a     substantial
financial   burden .
Spectrum  of   infectious   disease  process  in  the  kidney  presenting  as  acute
inflammatory  lesion  commonly  encountered  in    urological   practice
include
               Acute  Pyelonephritis
               Focal   and     multifocal bacterial  nephritis
               Renal    cortical     abscess ,         Perinephric       abscess
               Emphysematous     Pyelonephritis
               Pyonephrosis
2                          Course   of   the  renal    inflammation   depends    on   the
pathogenic    virulence   factors   ,   predisposing   comorbid   illness   and
conditions   in the  host  , severity  of  the   infectious  process  , the  time  of
presentation,  and  the  effectiveness  of  therapy  instituted.
                      Urosepsis occurring   as    a   result   of   severe   urinary    tract
infection   is    a    serious    condition   that   can    ultimately     lead   to   septic
shock  and   death.   High     degree   of    suspicion     on  possible  occurrence
of  urosepsis    in    all   cases   of   presumed    acute   pyelonephritis     is    the
single    most    essential     factor     in    making    an    early    diagnosis     of
complicated     renal     infection    and   preventing    sepsis .
                 Definitive   guidelines  for  optimal   management   of   acute   renal
inflammatory  lesions   have   yet   to   be   established.  The   best  treatment
strategy   must   be  the  one  that   improves   the   patient survival , relieves  the
distressing  symptoms  and   at  the   same time   maximizes   renal   salvage.
Minimal   invasive   interventions   have      been   advocated   nowadays  so   as
to  conserve   the   renal   unit .  Unfortunately,   these   minimal  invasive
management     strategies  have   variable    treatment    outcome     and   can
be  predicted  to  little  extent   by  the  presence  of  certain    risk  factors   in
the   individual
              This  study   is   intended    to    analyse    the    various     factors  that
can     influence    the    course     and    alter     the   outcome    of       the
inflammatory     pathologies    of     the    kidney.
3          Continuous   active   monitoring  is  required  in  patients  with  these
risk   factors   which   might    help  in   taking    timely  decision   either   to
preserve  the  kidney  or   perform     nephrectomy   if   they  fail  to  respond  to
the  initial   conservative   management.   Nephrectomy    contributes   often    to
a   complete    resolution   of      life   threatening   renal    infection   in   these
situations .
4AIMS OF THE STUDY
Aims  &  Objectives :
1. To   analyse    the    risk   factors    predisposing    the    acute
inflammatory    lesions   in    kidney .
2. To   evaluate   the   factors    determining    their   clinical    course  –
Recovery  from   disease   /   Nephrectomy
3. To  discuss  the  management   options   and    factors   influencing
their   success.
5REVIEW    OF   LITERATURE
                    Urinary   tract   infections (UTIs)  are   among   the   most  common
conditions   requiring   medical  attention  .  It   results  from   invasion   of   the
urothelium   by    bacteria  that   terminate    in   an  inflammatory   response.
               Interactions   between  the  uropathogen   and   host  result   in  UTIs
and     the     pathogenesis      often     involves    several   processes.    The
uropathogen      initially    attaches to  the  epithelial   surface  where  it
colonises  and  disseminates   throughout   the   mucosa  causing  tissue
damage.    Pathogens    can     then     ascend    in   to   the    urinary   bladder
resulting  either    in    symptomatic   infection   or   asymptomatic   bacteriuria.
Disease     progression   further     may    lead    to   pyelonephritis    and   renal
impairment.
          Virulence   factors   of   the  uropathogens   are  responsible   for
bacterial   resistance   to  the   normally   effective   defence   mechanisms  of
the   host.
                  Depending    on    the   anatomic    or    functional   status    of    the
urinary  tract   and    the    health   of    the    affected   host,    UTIs    can      be
divided   in   to
Uncomplicated     UTI   and    Complicated    UTI
6Uncomplicated    UTI  :
           Describes  an  infection   in  a  healthy  patient    having    a    structurally
and  functionally  normal  urinary tract [1]. The  virulence   properties  of    the
causative   bacteria    serve    as     the    predominant    factor   leading  to  the
infection.   Majority    are    women    presenting   with   isolated  or   recurrent
bacterial  cystitis  or   acute  pyelonephritis. The   infecting   pathogens  are
usually   susceptible  and    eliminated   by   a short   course   of   commonly
used     oral   antimicrobial   therapy.
Complicated    UTI :
                Describes     an    infection    occurring    in     a  patient    with     an
anatomically   abnormal   urinary   tract  or   significant   medical  or   surgical
comorbidities. The  host    immune   deficiency   in  its   various   forms  serve
as   the  major   cause  .   Structurally   or  functionally   abnormal  urinary tract,
compromised   host  , increased  virulence  or antimicrobial  resistance  of
bacteria   contribute.  Majority    are   men.  Removal  of   the   complicating
factor   in  addition  to  the  high  doses  of   antibiotics   is   essential  for
successful  treatment .
        A complicated   infection  is usually   associated  with  factors  that
increase  the  chance  of  acquiring  microbes  and  decrease the   efficacy  of
therapy   (Table 1).
7                       TABLE  1 :  Risk   Factors  For  Complicated  UTI
Both  pathogenic  ( organism  related )    and   host  factors   determine  the
severity   of   the  infectious  process    and  thus   influence  the   course  and
outcome  of   the   inflammatory   lesions   of  the  kidney.
Host factors: Patients  at   risk    for   complicated UTI
A.   Intubated   urinary   tract:
           Patients  with   an   intubated   urinary tract,   with  an  indwelling
catheter (urethral,    suprapubic,   Nephrostomy, or  others) or   an   internal
one, such as a ureteral or urethral   stents are  at risk   for complicated UTI .
Reasons   being
  i) These  patients   are   always  at   increased  risk  for  infection   and    due
to  subsequent  exposure  to   multiple courses   of   antibiotics ; they   are
prone    to   infections  with    resistant   organisms.
ii) Urinary   findings  of   infection  are    indistinguishable  from  those with
sterile urine, from the perspective   of  the  urinary   chemistry and  microscopy.
In the presence of an indwelling catheter ,the  urine will become colonized, if
not infected  by  the   2-week time period. The    usual   organisms   tend  to  be
8uropathogens, but occasionally  skin   flora or vaginal organisms predominate.
Often it is difficult to distinguish   colonization   from  frank  infection in the
setting of   an indwelling  catheter.
B.   Urinary obstruction
The patient with a known urinary  obstruction,  whether   it involves the
upper  or   lower urinary  tract,  have  high propensity  to  develop complicated
UTI. [2]  Obstruction  cause   prolongation   of  bacteruria  by mechanical
means  and   also  interferes with   the   local  and systemic  immune response,
preventing  its functioning  at optimal  levels. Obstruction    prevents    the
normal  flow of urine, and  the  resulting    urinary    stasis   compromise    renal
and  bladder    defence  mechanisms.  Bacterial   growth    in   urine   and   their
ability   to adhere to  the  urothelial  cells  is   increased   following  stasis .
             The   infectious   process   itself   increases the degree of obstruction.
This  is  accomplished   by  bacterial  alterations  of  the environment  in the
course of the infection, resulting  in swelling and prevention of peristalsis .[12]
The    presence  of   obstruction causes the kidney to have a reduced ability to
excrete and concentrate  antibiotics as well, and   also  reduce the   ability of the
drug   to function   because of  the  extended   presence   of   bacterial   products
in  the environment.
             In   the setting   of  obstruction,  an   infection  is  usually   viewed as an
undrained  abscess     which   depend upon the degree of obstruction and  also
the level of  obstruction . In most cases,  drainage  is indicated,  usually on  an
9urgent or even  emergent  basis.  Even   mild   episodes   of    pyelonephritis  or
cystitis   in  situations  where   obstruction   to   urine   flow  is   present   can
become  life  threatening   . It  becomes  essential  to  relieve   the   obstruction
in  these   situations   for  a   successful   outcome.
C.   Male Gender
             Urinary   tract    infections    are     more    prevalent  in women  because
of  their   short  urethral   length  which  allows   easy   bacterial  colonisation
of   the  bladder. At   least  20%  of   women   experience   a UTI   in their life
time.
                   Most    clinicians   suggest  that   male  gender  alone   can   be   a
criteria   for  being a complicated   UTI . [1,3] This is  especially true  in the
older  individual   who   are   likely  to  have   benign prostatic hyperplasia, and
thus  presumably  a  lower urinary tract  obstruction. [4] Males   have   several
advantages over females when it comes to urinary  tract infection susceptibility;
an infection in  male   should  raise suspicion of an underlying condition. The
presence  of   an   elongated   urethra   and  the  antibacterial nature of prostatic
secretions combine  to reduce the incidence of UTIs in male as a whole. [5]
Thus, infection in a male suggests   underlying    abnormalities  predisposing  to
complicated  infection.
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D. Age
                    Age is always a consideration when considering   the existence of a
complicated  UTI.  Old   bed ridden  patients  with  catheter  poses  greater
risk.  Infections  in   childhood  gives  clue  to   certain  abnormalities of  the
genitourinary tract. [6,7] Vesicoureteral  reflux, urethral valves, ureteropelvic
obstruction, or  ureterovesical  obstruction    are some  of  the   relatively
common  conditions where there is increased  incidence of urinary tract
infections, as well as increased severity.  Gender   here  is important as well, as
most  of  the       congenital   genitourinary    abnormalities  are   commoner  in
boys  than  girls.
E.  Diabetes mellitus
            A number of medical conditions have  found   to   be risk factors for
UTIs, and  they   lead to a more protracted course of therapy with  potentially
adverse outcomes because of specific  complications. Most important   among
them  is Diabetes mellitus (DM). Not only are these   patients   more
susceptible to UTIs in general,  complications    are   observed    far  more
often  than  the   normal  individuals.[8] Perinephric  abscesses  are   rarely  seen
in  patients   without  obstruction, except in the setting of diabetes, particularly
when there is poor glucose  control. This   is also true for lobar   nephronia,
intrarenal  abscesses, or carbuncles.  One   condition   that   is   almost
exclusive   to   diabetics   is emphysematous pyelonephritis.[9] This   specific
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case of renal  infection  is manifested by the presence of  gas in the renal
parenchyma. The condition has   a mortality rate that exceeds 40% and often
results  in loss of the affected kidney.
                      Secondary   obstruction   may   also   be  seen  in DM because of
the   sloughing  of   papillae. This   condition  called  as renal  papillary
necrosis results in obstruction  of the upper urinary tract by mechanical means.
The pathophysiology is a result of pyelonephritis  in a patient with
compromised intrarenal  bloodflow  like   diabetics. The  condition  presents   as
an emergency requiring  immediate   drainage by either a retrograde or
antegrade technique.
While   women  with  diabetes   mellitus  have   high   occurrence   of   clinical
asymptomatic  and  symptomatic   UTIs ,  there  is  no  increase  incidence
among  diabetic men. Hospitalizations   for  acute    pyelonephritis  in  diabetics
are   more  common   among    women (10.86/10,000)   than   for    men
(3.32/10,000).
                       Upper   urinary  tract  is   involved   in  nearly  80%   of   diabetic
patients    as  evident   by   localization  studies  (Forland   et   al, 1977).
Infections   in  diabetics   are  commonly   caused    by   atypical   organisms
such  as  yeast  and  can     result   in upper   tract   infections  with   significant
complications   such  as papillary  necrosis,   emphysematous   pyelonephritis,
renal   abscess   or   perinephric   abscess.
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F.   Renal   insufficiency
               Patients   with   renal   insufficiency   are  another  high-risk  group
known  to   develop   complicated   UTIs.  The  most  common  reason  being
reduction  in  renal  blood  flow  that  most   often  accompanies  this  disease.
The   secondary effects   include  a  reduced  immune response, both on the
local and  systemic level . Reduced urinary  volume  and   impaired    host
defences   increase  the   bacterial  capability to   colonize the urinary tract. The
delivery of  antibiotics  is compromised, making  eradication  of infection
difficult .  Lastly, patients   on    both    hemodialysis  and  peritoneal   dialysis
have  an increased incidence of  UTIs, and some  are   secondary to infections
elsewhere .[26]
G. Immunosuppression
                Patients  who are   immunosuppressed, either by  medications   or by
other   comorbid    conditions,  must always be treated aggressively. [10] The
secondary effect  of  the  immunosuppressant  drugs  is  the   increased
susceptibity  for   infections throughout the body, including  the urinary  tract.
The  prototype  of  these  is corticosteroids. These drugs  irrespective  of  their
route  of  administration   cause  immunosuppression  in a dose dependent
fashion by reducing the cell-mediated immune  responses and local immune
reaction.   There  is  also an effect on the  humoral   immune system, although
this   is not as  pronounced.
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                  Drugs  such as  the  calcineurine    inhibitors    (cyclosporine     and
tacrolimus )  are  cell-mediated   immunity   specific.  Monoclonal   antibodies
such  as muromonab-CD3 and a host of others  which   are currently being
used to treat transplant rejection  have  profound effects on the treatment of
UTI. The cell-cycle nonspecific drugs, such as  azathioprine and mycophenolate
mofetil, are  also  a concern, as they are not only used in treatment   of organ
transplantation, but also in other diseases.
H. Urolithiasis
                   Urolithiasisis   certainly one of the medical   conditions that confers
the designation of ‘‘complicated’’.[11] The most ominous complication of stones
is obstruction. The association of an obstructing  calculus along with febrile UTI
is usually  considered an emergency, because of the risk of  sepsis. Intervention
is mandatory in most cases,  specifically   by employing   either  a nephrostomy
tube   or   a   ureteral   stent.
                  Stones  often   prolong  the treatment of  UTIs  if they are infected.
The   bacteria  become  concealed  in  the interstices  of  the  stone  and  form
their   own   biofilm  environment  which   make  infection  difficult  to
eradicate without  removal   of the calculus. Stones   also cause injury to the
urinary  tract, and this   damage can give bacteria  a place to establish
colonization.
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               Certain  stones    form   as  a   direct  result  of   infections, specifically
magnesium  ammonium  phosphate or calcium carbonate stones. Urea   splitting
microorganisms, by altering their microenvironment, facilitate precipitation of
these   salts, promoting  de novo stone formation and thus persistence  of
infection. If the bacteria come in contact  with other types of stones , they may
lay down new matrix  upon  the existing stone, creating   an  eclectic  mix of
calculus material.
I. Surgery of the Urinary tract
                  Whenever   surgery  of   the  urinary tract performed, either  for
obstruction, calculus, or  other causes, the urinary tract  becomes more
susceptible   to UTIs  and  persistence  or recurrence of  infection  occurs .
Disruptions   or  irregularities of the  urothelium  may serve as an initiation
point for UTIs  or the creation of obstruction. The underlying   abnormality may
not have been entirely corrected  which  may  serve  as  a  risk factor for
infection . Sutures   utilised  in the  surgery may persist in the urinary tract, even
when  the material is designed to dissolve. If   sutures  remain  long enough,
colonization may occur, and stones   may  occur.
J. Functional and   Anatomical  abnormalities  of the  Urinary tract
                  There   are  a number   of     urinary  tract  abnormalities  which can
be   either   anatomical  or    functional   that  may  lead  to  complicated  UTIs.
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Most of   these  are  congenital  and present   early  in  life  with voiding
dysfunction . Vesico-ureteral  reflux, ureteropelvic  junction obstruction,
urethral valves (anterior or posterior), and congenital megaureter  are some  of
the most common abnormalities  which   are   associated with an  increased
incidence of UTIs,  as well as a need  for prolonged antibiotic therapy or
intervention. Correction of these abnormalities may   reduce   the risk of UTIs,
but their  occurrences  in   the setting   of an infection implies a complicated
label .[12] Structural  abnormalities   like   polycystic   kidney  disease, calyceal
diverticula, medullary sponge  kidney, renal artery stenosis, renal vein  varices
or thrombosis,  and  many   others  lead  on to  complicated  infection. Although
some of these  may be corrected or near-corrected  with surgery and
medications, the risk for a complicated  UTI remains greater than  among the
general population, and should be  managed accordingly.
K. Pregnancy
                    Pregnancy always confers complicated   status  on  any UTI .[13,14]
Complicated   infection  lead  to   increased  risk  to  both  the  mother  and
fetus. The   gravid uterus, depending  on the  trimester, will  cause   an
anatomic alteration  that  involves  a  relative  obstructive   uropathy. Drainage
is   not   needed   usually   ,  but   must     be    considered    in  high    grade
obstruction  to   relieve  symptoms . After   clearance   of   the  UTI,  decision
regarding  prophylactic   antibiotics  is  warranted.
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                      The   hormone  status   also  has a significant bearing on the
infection management .A reduction in  smooth muscle   contractility, not only of
the uterus, but also of the ureter and  bladder, may confer a degree of
obstructive  uropathy.It has been shown that progesterone levels  correlate
closely with reduced  ureteral  motility  and may both predispose to UTIs and
prolong  their treatment. The  voiding  dysfunction  manifesting  as  frequency
and urgency, along with stress incontinence, that almost  invariably
accompanies a pregnancy also negatively impacts the resistance to and
treatment  of UTIs.
               Increase in bladder   pressure   and   associated  venous congestion
may further   contribute to the  increased  susceptibility. These    conditions
disrupt the   tight     junctions   in   the   bladder   epithelium  and   the
uromucoid layer  (a protective  layer of mucus, Tamm- Horsfall   protein  and
other  substances)  and they  fail  to prevent infection.
             Bacteriuria  prevalence   in   the    pregnant   women varies   from 4% to
7%, and  the  incidence   of   acute   clinical  pyelonephritis    is   about   25% to
35%   if  left  untreated .
      L.    Voiding   Dysfunction
  Patients  with   voiding   dysfunction, including   those    with neurogenic
bladders, comprise  a significant  proportion of complicated UTIs. [15]  Prime
reasons  are  :
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i) Frequent  presence of   residual  urine
Conditions   such as  low spinal cord injury, myogenic   atony,spina  bifida,
sacral agenesis and  others  may  cause  incomplete emptying and  thus   an
enhanced   milieu for bacterial growth. This can also  be a result of bladder
outlet obstruction, either anatomic   or physiologic.
ii) Presence of   high   pressure voiding  and its  effects
The first is a reduction  in blood supply, impairing  immune  response  and host
response.   Second, the high pressures  disrupt  the  uromucoid  layer and may
separate  the  urothelial  cells, all   causing a facilitation of bacterial binding and
ultimately  colonization.   Lastly  ,as  the  bladder  damage  progresses  over
time, cellules and diverticula may emerge,as does secondary vesicoureteral
reflux. These   lead to incomplete emptying, which greatly contributes  to the
sequestration  of bacteria, establishment   of individual microbial ecosystems,
and  reduced clearance by drugs, as well as renal   insufficiency.
M. Environment – Nosocomial  infections
                     Hospital  acquired  or nosocomial  infections  must   be considered
complicated because of a host of factors. [16]  Indwelling  catheters  and other
breaks in the body’s integument provide  for initiation points  for  the infection.
The  enormous  amount    of  antibiotics    used   in  this  environment   leads  to
emergence of   resistant  bacterial  species .  Another  problem is   cross
contamination from patient to patient transmitted by the health care  providers
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themselves. Hospitalized   patients  contracting   UTIs   have   mortality   rate
reaching  30% .[17]
Pathogenic factors: Organism related factors contributing to
                                      Complicated UTI.
The   organisms   implicated in causing complicated   UTIs   are    varied    (
Table 2)
                      TABLE  2: Common  Bacterial  Pathogens
I. Gram negative  Organisms :
                    The  initial   infection  typically   is  caused  by Escherichia  coli.
It  is the most common facultative aerobic organism in the gastrointestinal tract
and is  in  close proximity to the genitourinary tract.   E. coli has a number of
survival  advantages  to  establish  a colony, and ultimately  an  infection, over
other Gram-negative species. Many subtypes of  E.coli  are  possessing   surface
structures that bind to  specific locations on the  urothelial cell surface. Most
important  of   these  are  fimbria  which  includes
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a) Type  I  fimbriae, which are inhibited  by mannose and  avidly bind to latex
catheters  and   urothelial cells [18].
b) P-fimbriae,which  bind to a  urothelial cell surface  receptor referred to as
the P-blood group antigen   present in the majority of the world population   and
located on the urothelial cells as well [18]. Those with the P-blood group antigen
are   able  to ascend the urinary tract easily, even in the anatomically   normal
system.   P  fimbriae   is   implicated    in E. coli pyelonephritis. Epidemiologic
studies   have consistently   demonstrated   that   these  adhesions  are present in
almost   100% of  strains  causing    pyelonephritis .[19]
Many   other   Gram-negative species  may  also   be   found   in  the
complicated  UTI group.  Most   of   these  are  nosocomially acquired .  In   the
setting of an  indwelling   catheter  multiple species may colonize the catheter,
and thus the urine. Not  all  species are  capable  of causing a true infection, but
they   may  complicate  the  circumstances   in  other  ways  which  include
a) Sharing   of     genetic material,  both   chromosomal or  naked   DNA, often
referred to as ‘‘plasmids.’’ which  may   readily spread  throughout a bacterial
population  by conjugation and other means, result   in   multiple antibiotic
resistant  infections [20].
b)  Certain    bacterial    species   appear  to  have  a  great  survival advantage
due  to  presence  of   matrix   or   glycocalyx   synthesis  (also referred to  as
biofilm ) [21,,22].
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                   Certain    bacteria,  the  prototype  being   Pseudomonas
aeruginosa, are   able  to synthesize a substance into their  micro  environment,
which forms a protective   shell   around    themselves   which    protect  them
from   the    body’s   immune     response   as   well   as   cause    exclusion    of
antibiotics .
II.  Gram  Positive  Organisms
                  Other   than   Staphylococcus   saprophyticus,  and  rarely group D
streptococci  (enterococci), infections   caused   by  Gram-positive  species are
more   commonly seen in complicated UTI groups. The  reasons  being
i)  Most   species   lack   the   external   appendages  to   bind   avidly  to   the
     urothelial   cell  surface, and  thus   have   a   lower   probability   of
     establishing  a  colony  to   initiate   the   infectious   process.
ii) These   species   are  not   as   ubiquitous   in   the   area  in   and    around
the
     urethral  opening   nor   seen   in   the   colon   or   mucosal   surfaces.
iii) They often lack specific virulence factors  to allow them  establish   a colony
      and invade.
               Gram-positive   organisms may   spread  via  the  hematogenous  route
and tend to   be   a  result  of  a  significant   insult   to  the   body’s   defense
mechanisms. An example of  this  is Staphylococcus  aureus infection, which
often   can come from an infected site elsewhere in the  body, causing
bacteremia and therefore seeding  of the kidney [23]. This  usually  occur  in the
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circumstance  of an intravenous drug abuser or someone  with  infected
indwelling line. These  infections cause   complicated  UTIs, specifically lobar
nephronia  (renal carbuncle) or  perinephric   abscess,  requiring  long-term
antibiotics or intervention ,either   endoscopic   or    surgical.
          III . Fungal  infections
Another group  of pathogens that are included   in the complicated group are the
fungi. The most  among  them   is the  genus  Candida, with the species
albicans, tropicalis ,and kruzei predominating. These yeast forms   are
frequently found in the urinary tract as a colonizing   agent, rather than an
infecting organism[24] and acquire  greater significance in the setting of an
intubated  urinary  tract.
                      Candida    accounts  for less  than  5% of complicated UTIs. Other
fungi  comprise   a very tiny percentage, with  isolated  case reports of
prostatitis,   pyelonephritis, and  other infections caused   by fungi other than
candida.
SPECTRUM   OF  ACUTE  INFLAMMATORY  RENAL  LESIONS
I. Acute Pyelonephritis ( APN )
           Traditionally    defined   as   inflammation  of   the   kidney  and   renal
pelvis, but  the   diagnosis  is  mostly    clinical.   Many    patients   with  APN
present   with   mild symptoms   and   can  be  managed  in  as  outpatient.[25]
About  10%  to  30%  of patients   with  APN  require  hospitalisation [26] and
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may  even  present   with  life-threatening   complications   including   shock,
septicaemia   and multi-organ dysfunction syndromes. The mortality rates
ranges from 1% to 12%.[ 27, 28]
Clinical   Presentation :
           Patients   have    acute    onset  of   fever (100° F or greater),  chills  ,
unilateral  or  bilateral   flank  or  costo vertebral angle  pain   and  / or
tenderness. Lower   tract   symptoms  like   dysuria,   increased urinary
frequency,  and    urgency   may   be   present  .    Hill [29]  defined    APN
pathologically as a  suppurative   inflammation of  the   renal   parenchyma  and
pyelocaliceal system typically  distributed  along   one  or   more  medullary
rays supporting   an ascending route  of   infection. There  is   often  poor
correlation  between the  clinical  symptoms   and    the  site  of infection .
Previous   history  of    lower UTIs is  present  in  approximately  75%  cases.
There  is  costovertebral   angle   tenderness    during    deep   palpation   on
physical   examination  .
                      Acute  pyelonephritis     may  have   asymptomatic   progression
to  chronic  pyelonephritis,  especially   in  compromised  hosts,   without  any
symptoms.  Acute    renal   failure   may   be   the   presentation   in  rare cases .
Laboratory Diagnosis:
Numerous   WBCs,  often  in  clumps, and  bacterial   rods  or
chains   of   cocci  are   seen  in  urine  analysis . Leukocytes   showing
Brownian   motion   in   the   cytoplasm  (glitter cells)  are   seen in  hypotonic
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urine , but    are  not  diagnostic   of    pyelonephritis.  Granular   or  leukocyte
casts  are   suggestive   of   acute  pyelonephritis  and  these  are readily
demonstrated  by  staining  urinary  sediment  with  basic  dyes   like  dilute
toluidine   blue  or KOVA   stain.
                   Blood    tests    show     leukocytosis   with   a   predominance  of
neutrophils,  increased   erythrocyte   sedimentation  rate, elevated  C-reactive
protein  levels, and   elevated  creatinine   levels  if   renal  failure  is  present.
Creatinine    clearance    may   be   decreased. Blood cultures may be positive.
Bacteriology:
Urine   cultures  are  usually    positive,  but  are  negative   in  20%
of patients    due  to   lesser  colony   count . E. coli,  accounts   for  80%   of
the   cases.  Multiple   antimicrobial  resistant   clonal   groups   are  seen  in
community –acquired  pyelonephritis  .  More   resistant  species like   Proteus,
Pseudomonas,   Klebsiella ,  Enterobacter,  Serratia  or   Citrobacter   should be
suspected in   patients   presenting   with   recurrent UTIs. Except  for  E.
faecalis, S. epidermidis, and    S. aureus,  gram-positive    bacteria   rarely
cause pyelonephritis.
                     Blood   cultures   are   positive  in   about   25%   of   cases   and
most  resemble    the   urine   culture .  They   do   not   influence   decisions
regarding    therapy. Blood   cultures    should  therefore   routinely  not
obtained   for   the   evaluation   of   uncomplicated  pyelonephritis  but
performed   only   in  those   with   systemic   toxicity  or   those    requiring
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hospitalization   or   with   demonstrable   risk   factors  such  as   pregnancy
(Velasco et al, 2003).
Imaging  Studies:
                 Ultrasonography   and    Computed  Tomography  are    utilized  to
evaluate   patients  initially    for    complicated  UTIs  and  are   useful  in    re-
evaluation  of   patients  who  are  not  responding   after  72  hours  of   therapy.
Ultrasonography    depict   hypoechoic     or  attenuated   parenchyma,  renal
enlargement   and   a compressed  collecting  system.   Contrast  computed
tomography (CT)  scans  show   hypoenhancing  regions  with  or  without
renal  swelling   and   can   be focal or diffuse. To standardize   terminologies,
Talner et al [30]  in 1994  suggested    that  all   radiological   parenchymal
abnormalities  without  abscess  attributable  to acute infection  be called APN.
CT  scan    reveal  disorganized parenchyma  and abscess  formation  in  the
lalater  stages  with    renal  parenchymal  damage.
                    Radionuclide  imaging     are    useful   to   demonstrate  functional
changes  associated  with   acute  pyelonephritis  (decrease  in renal blood flow,
delay in peak function, and   delay  in  excretion  of  the  radionuclide)  and
renal   cortical   defects   associated   with   vesicoureteral   reflux.
Management :
                        Patients   with   presumed   uncomplicated  pyelonephritis   are
managed   as   outpatients  and   radiologic evaluation  are  usually  deferred.
Single   drug  oral   therapy   with  a   fluoroquinolone  is   effective . Single
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parenteral   dose   of   an  antimicrobial  agent such as   ceftriaxone, gentamicin,
or  a   fluoroquinolone   are   administered   by   some    before   starting    oral
therapy.  Amoxicillin  or  amoxicillin  /   clavulanic  acid   is  recommended  for
gram-positive organisms .
               If  a patient  show   uncomplicated   infection   but   is    sufficiently
ill (with  evidence  of  sepsis)    to  require   hospitalization   or    has
complicated  pyelonephritis,  or  fails  to improve with   outpatient  therapy  , a
parenteral   fluoroquinolone, an  aminoglycoside with  or   without  ampicillin,
or  broad   spectrum  cephalosporin  with  or without an  aminoglycoside  is
administered  .
              In    patients    with    known    or     suspected    complicated
pyelonephritis    renal  ultrasound   evaluation  rules  out   stones or obstruction.
Excellent   assessment  of   the    urinary   tract  status  , extent   and   severity
of   the  infection   is   done   by   CT  scan.   These     patients   require
hospitalization,  with   complete bed  rest, intravenous  fluids,  parenteral
antibiotics   and antipyretics.  An  obstructed   kidney   have  difficulty  in
concentrating    and    excreting   antimicrobial  agents   and   hence    any
significant     obstruction  has  to  be    relieved   expediently    by   the    safest
and   simplest  method .
Unfavorable    Response   to Therapy:
          Immediate   reevaluation   is  needed   in   these  patients  .Repeating  the
urine  and  blood   cultures  and  making   alterations  in  antimicrobial therapy
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is  necessary. CT  scan  is  employed    to    identify  unsuspected   obstructive
uropathy, urolithiasis , or  underlying  anatomic  abnormalities  which  aid   in
prolonging  the  infection,   preventing   a  rapid   therapeutic  response   and
producing   complications   such   as   renal  or  perinephric  abscess.
Follow-Up:
              Repeat urine cultures   are   done    on  the  seventh   day  of   therapy
and    10  to 14 days     after   discontinuing   antibiotics    to  ensure  that  the
urinary   tract  remains   free  of  infections. 10% to  30%  cases   relapse   after
a 14-day course of    therapy.
                        A   second  14-day   course  of   antibiotics  is  necessary  for
relapse    treatment   but   occasionally   a   6-week  course  may  be  needed.
Some    patients   may  require   additional    investigations   such  as   voiding
cystourethrogram,     cystoscopy  or   bacterial   localization  studies   and
correction  of    an  underlying   abnormality  of  the   urinary tract.
II. Acute  Focal   or   Multifocal  Bacterial   Nephritis
                 Acute  focal or  multifocal  bacterial nephritis is an  uncommon, more
severe   form of   acute  renal   infection  in which a heavy leukocyte  infiltrate
is confined to a single renal lobe (focal) or multiple   lobes(multifocal).
Clinical   Presentation:
Symptoms   and   signs   are    similar  to  that  of  acute pyelonephritis  but  are
usually  more   severe. More   than   half   of  the    patients   are  diabetic, and
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sepsis  is    common   . Leukocytosis   and   gram-negative   urine   culture   are
found .  Blood   culture   is  positive  in    more  than 50%   of  cases.
Radiologic  Findings:
The    diagnosis    is    evident   on   radiologic
examination.  On   ultrasonography    lesion    is     relatively  sonolucent  and
poorly  marginated    with   occasional   low-amplitude   echoes that  disrupt the
cortical   medullary  junction . Enhanced    CT   scan  studies   is   necessary
because  the  lesion  is   difficult  to visualize  on  the  unenhanced  study.
Wedge  shaped   areas   of   decreased  enhancement  are characteristic.
Definite  wall   is  not   evident   and  frank   liquefaction  is  absent.  It  has   to
be  differentiated  from   renal  abscess.  Abscesses   are  usually round   with
liquid  centers  and   are present   both    before   and  after  contrast  medium
enhancement. Chronic   abscesses    have  a ring   shaped   area of   increased
enhancement  surrounding   the  lesion  (Corriere   and Sandler, 1982).
Management:
             Acute   bacterial  nephritis  usually   represents   a   relatively early
phase of  abscess  formation  and   most   cases  progressed  to  frank abscess
formation. Treatment   includes   hydration and intravenous   antibiotics   for at
least 7 days, followed by 7 days of oral  antimicrobial therapy. Patients   rightly
respond to medical therapy, and   resolution  of  the  wedge-shaped  zones  of
diminished  attenuation  can  be  seen  in  followup  imaging  studies .
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         Failure   to   respond  to  therapy is an  indication  for   imaging   studies to
rule   out  obstructive  uropathy,  renal   or  perirenal  abscess,   renal carcinoma,
or  acute   renal  vein  thrombosis.
III. Emphysematous  Pyelonephritis (EPN)
                          Urologic  emergency  characterized  by  an  acute  necrotizing
parenchymal and  perirenal  infection   caused  by  gas-forming  uropathogens.
Majority   of  the  cases   occur  in diabetic patients.  High  tissue glucose levels
serve  as a   substrate   for  microorganisms  such  as  E. coli,  which  produce
carbon  dioxide   by   the  fermentation  of   sugar.  In   addition to diabetes,
most   patients have urinary  tract obstruction  associated with  urinary calculi or
renal  papillary  necrosis and   exhibit    significant   renal  functional
impairment. The overall   mortality   rate  is   reported   to  be  between   19%
to   43% in various studies.
Clinical   Presentation:
                All    documented    cases   are   adults  and  there  is  no  increased
risk  in  juvenile  diabetics .    Women   are  affected  more  often . The usual
clinical presentation  is  severe   acute  pyelonephritis, but    in  some  situations
a  chronic   infection   precedes  the   acute  attack. Many   patients  present
with  the  classic   triad  of   fever, vomiting, and flank pain.  Pneumaturia   is
absent   unless   the   infection   involves  the  collecting system.
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Labarotory    Investigations :
                 Urine   cultures    are   usually   positive  with    E.  coli   being  the
most commonly   identified  organism.   Klebsiella   and Proteus   are   less
common.
Imaging   Studies:
              Plain  X-ray  shows  tissue  gas    distributed  in  the   renal
parenchyma   as  mottled  gas  shadows over  the involved kidney. A  crescentic
collection of  gas over the upper pole of the kidney is more characteristic  .Gas
extends to  the  perinephric  space  and retroperitoneum   as  the   infection
progresses.  USG     usually  demonstrates   strong   focal   echoes   suggesting
the    presence    of  intraparenchymal   gas.   CT   Scan   is    the    imaging
procedure of  choice  in defining the extent of the emphysematous process and
guiding management .
 25%   of    cases  demonstrate    presence  of  obstruction  evident  by  imaging .
Radioisotope   scan  should   be performed to assess the degree of renal function
impairment in  the involved   kidney and the status of the  contralateral kidney.
Management :
            Emphysematous    pyelonephritis    is   considered     a    surgical
emergency. Most   patients   present   with   sepsis ; fluid  resuscitation  with
broad  spectrum  antibiotics   are   essential.   Medical   therapy   can   be
considered  in  a  functioning  kidney .  Nephrectomy   is  recommended  in
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patients   who fail to   improve  after a few days of   therapy. If   the  affected
kidney is non-functioning  and  not  obstructed,  nephrectomy  should  be
performed    since   medical  treatment  alone  in  such   situation  is   usually
lethal. If  a  kidney is  obstructed,   prompt  drainage  must   be  instituted.  If
condition   of  the   patient  improves, nephrectomy  may be   deferred   pending
a   complete urologic   evaluation.
IV. Renal  Abscess
                      Renal abscess  or  carbuncle  is  a collection  of  purulent  material
confined  to  the  renal  parenchyma .Previously   80% of  cases   were attributed
to  hematogenous  seeding  by staphylococci   but  since  1970, gram-negative
infections   are  the   major  source   of  the  cases.
              Ascending  infection  along    with  tubular  obstruction  from previous
calculi    or   infections    appears  to  be  the  primary  pathway .Two-thirds  of
gram-negative  abscesses  are   associated  with  renal   calculi  or  damaged
kidneys.  Hematogenous   renal  seeding by gram-negative   organisms   may
occur  but  rare.  Recent   studies    indicate   that   reflux  is   frequently
associated  with  renal  abscesses  due  to   persisting  infections.
Clinical    Presentation:
                   Fever,   chills,   abdominal  or   flank  pain  and  occasionally
weight   loss    and   malaise   .  Symptoms    of    cystitis    may   occur.
Occasionally   symptoms    are    vague   and   may   delay   the   diagnosis .
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Thorough   history   may  reveal  a  gram  positive   source   of  infection  before
the onset of urinary tract symptoms. Multiple   skin   carbuncles   and
intravenous  drug   abuse  introduce  gram positive  organisms  in to  the  blood
stream.    Complicated    UTIs    associated    with     pregnancy    ,   calculi    ,
neurogenic  bladder   and diabetes  mellitus   predispose  the  patient to abscess
formation.
Laboratory   Diagnosis:
          Marked   leukocytosis   present  .  Blood   cultures  are  usually  positive.
Pyuria  and  bacteriuria  not  present   unless  the  abscess  has  communication
with   the   collecting   system.  Urine   cultures   shows   no    growth    or   a
different  microorganism   in  gram-positive infection while  the  same organism
is isolated   from  the   abscess  in  gram  negative   infection .
Imaging  studies:
                    Ultrasonography  show  an  echo-free  or  low-echo  density   space
occupying  lesion  with  increased transmission .The margins of an abscess are
indistinguishable   in the acute phase   but  become  well  defined  in  the  later
stages. Internal   appearance  of  the  abscesss   may  vary from a virtually solid
lucent mass to one  with   increased  numbers of low-level internal echoes.
               CT Scan  is  the  diagnostic procedure of choice  and  provides
excellent delineation of the tissue . Initially,  CT  shows  renal  enlargement
and    focal, rounded   areas  of  decreased   attenuation  ,  later  thick  fibrotic
wall begins to form  around the abscess. An echo  free or  slightly  echogenic
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mass   due   to  the  presence  of  necrotic debris  is  seen.  Chronic  abscess   are
characterized   by    the   obliteration   of  adjacent  tissue   planes  and
thickening   of   Gerota   fascia.  Round   or  oval   parenchymal   mass  of  low
attenuation   with  a  surrounding  inflammatory  wall  of   slightly   higher
attenuation   forms  a  ring
The ring   sign is caused  by the  increased   vascularity   of   the   abscess
wall. Radionuclide   imaging   with   gallium  or  indium is sometimes  useful .
Management :
           Small   abscess less than 3 cm in diameter   are   managed
conservatively   with  the  course  of  intravenous  antibiotics  and  careful
observation . In  hematogenous  dissemination  where   there  is  higher  chance
of   penicillin-resistant  Staphylococcus,  a    penicillinase  resistant   penicillin
is  prescribed .    In  case  of   Penicillin hypersensitivity, Vancomycin  is
utilised. Gram -negative pathogens   are  treated  with    intravenous   third-
generation  cephalosporins, antipseudomonal  penicillins, or  aminoglycosides .
            In   larger  abscess ,   Percutaneous   or  Open  incision  and  drainage  is
the  classical   treatment . CT scan  or USG  guided  needle  aspiration   is
necessary  to  differentiate  an  abscess  from  a   hypervascular  tumor.  Culture
of  the  aspirated  material  done  to   direct    appropriate  antimicrobial
therapy.
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             Patients  are   followed  up   with   serial  examinations  with  USG   or
CT scan  until  the  abscess  resolves. The   common   causes   of   deteriorating
clinical course  include   misdiagnosis   , uncontrolled  infection with  formation
of  perinephric  abscess  and  infection with  resistant  organisms.
               Abscesses    3  to  5  cm  in   diameter  ,   smaller    abscesses    in
immunocompromised   hosts  and  abscesses   that  do  not  respond    to
antimicrobial  therapy  should  be  drained   percutaneously. Surgical drainage,
however, currently    remains  the    procedure   of   choice    for   most   renal
abscesses   greater  than   5 cm  in diameter.
V. Perinephric  Abscess
Etiology:
Perinephric   abscess  usually  results  from
1. Rupture  of  an  acute  cortical  abscess   in to  the  perinephric  space
2. Hematogenous   seeding  from  sites  of  infection ( 1/3 rd of the  cases )
3. Secondarily  infected  perirenal  hematoma  by  the  hematogenous  route
or  by  direct  extension  of  the   primary  renal  infection.
High risk  patients  include  patients  with  pyonephrosis ;  particularly
associated  with    calculus,  Diabetes  mellitus  ( approximately one third of
patients ) and  polycystic  renal  disease patients  who are  on  hemodialysis  (
mechanism  is not  clear;  may   be  due  to  limited    bioavailability  of  drugs
in  cysts ).
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            Perinephric  infection  ruptures  through  the  Gerota  fascia  in to  the
pararenal     space  to   form  paranephric   abscess.  It   can  also    result   from
infections    of  the  bowel,  pancreas, or  pleural cavity.
               Perinephric   or    psoas    abscess    can   occur   as   a   result   of     of
bowel   perforation, Crohn ‘s  disease  or spread  of  osteomyelitis  from
thoracolumbar   spine.   E.  coli,  Proteus,  and   S.  aureus    account   for    most
infections.
Clinical   Presentation :
               The   onset   of    symptoms  is   usually   insidious.  Symptoms  are
present  for more   than  five   days  ( only  10%  have  it  in   pyelonephritis ) .
Clinical  feature  is similar  to  that  of   pyelonephritis  but  more   than   one
third of  patients  may  be  afebrile. Abdominal or  flank  mass  can  be  felt  in
about  half  of  the  cases. Psoas  abscess  should   be  suspected  if   the   patient
has  a  limp  and  flexion   and external   rotation of    the   ipsilateral   hip.
Laboratory  Investigations :
               There  is   marked   leucocytosis. Elevated   levels of   serum
creatinine, and  pyuria  in  more than 75% of cases. Urine  cultures are  positive
in only 37%  of   cases. Blood   culture, particularly with multiple organisms,
was  often  indicative   of     perinephric     abscess  (  Positive   in   only   42% of
cases ).   Therapy   based  on  the   results   of    urine   and   blood   cultures
often   may  be   inadequate.
35
IMAGING:
                CT  Scan   is     valuable  for   demonstrating  the  primary abscess.
The   abscess   may  be  confined  to  the   perinephric  space or  extend   in  to
the  flank  or   psoas   muscle.  CT  scan    delineate    the   route   of    spread   of
infection  in  to  the  surrounding  tissues  and  thus  helpful in  surgical
drainage.
             Ultrasonography     shows    anechoic  mass  displacing  the  kidney  to
an  echogenic  collection  that  tends  to  blend   with  normally  echogenic  fat
within  the  Gerota  fascia .
MANAGEMENT :
             Primary   treatment   for   perinephric  abscess  is  drainage;  successful
treatment   by  antimicrobial    agents     alone  are   unusual  .   Image    guided
percutaneous  aspiration   and   drainage  of   small    perirenal  collections   is
possible.  They  are  usually   contraindicated  in  large  abscess  cavities  filled
with   thick,  purulent  fluid.   Gram  stain  of  the  purulent  material     guide
in  appropriate     antimicrobial   therapy.
             If  the  patient’s  condition  is  good,   nephrectomy   can  sometimes
be  performed  along   with   drainage  of  the   perinephric  abscess. In   other
situations    it  is  best to drain  the perinephric  abscess   first  and   correct   the
underlying  problem  or  perform a  nephrectomy  when  the  patient’s  condition
improves.
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VI. Pyonephrosis
               Infected    hydronephrosis    is    bacterial    infection   in   a
hydronephrotic   kidney.  The     term    pyonephrosis    refers  to   infected
hydronephrosis   being  associated with  suppurative  destruction  of   the
parenchyma of  the kidney resulting  in  total  or  nearly  total  loss  of   renal
function.Where  infected  hydronephrosis   ends  and   pyonephrosis   begins  is
difficult to determine clinically. Rapid  diagnosis and   treatment  of
pyonephrosis  are  important   to avoid   permanent   loss  of   renal   function
and  to  prevent     urosepsis.
Clinical   Presentation:
           Patient    is    usually    severely     ill,   with  presence   of     high   fever,
chills, flank  pain, and  tenderness. Sometimes   a  patient  may  have  only an
elevated temperature  and  a  complaint   of  vague   gastro   intestinal
discomfort. Past history   of   urinary tract calculi, infection, or surgery is
common. Bacteriuria  may  be  absent  if   the  ureter  is   completely
obstructed.
Radiologic Findings:
             Ultrasonography    in   infected  hydronephrosis    demonstrates
internal   echoes   within    the   dependent    portion    of     a    dilated
pyelocalyceal   system.  Focal   areas   of     decreased  echogenicity  seen
within  the  hydronephrotic  parenchyma   suggests   pyonephrosis.   CT is
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usually nonspecific  but may  reveal   thickening  of  the  renal   pelvis,
perirenal  fat  straining , and  a  striated   nephrogram.
Management:
        Once   diagnosis  of   pyonephrosis is   made, treatment  is initiated with
appropriate  antimicrobial  drugs   and   drainage   of   the   infected   pelvis.  A
ureteral  stent   can  be  passed  to drain  the   kidney  but   thickened  pus   may
clog   the   stent   resulting  in  poor  drainage  .In  such  cases   percutaneous
nephrostomy  tube   should  be   placed (Camunez et al, 1989)  When  the
patient becomes  hemodynamically  stable, other   procedures   are  needed  to
identify and treat  the   source  of   the   obstruction.
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MATERIALS  AND  METHODS
1. Study   Group   : Patients  who  were   admitted  with  features  of  acute
renal     inflammation    at  1) Kilpauk   Medical  College    Hospital  and  2)
Government      Royapettah    Hospitals , Chennai.
2. Study   Design : Prospective  clinical   study
3. Period   of  Study: January  2012  -  January 2013
4. Total  number  of  cases   :   30   patients
4. Data  Analysed  : Risk  factors,   Clinical   manifestations,
                                 Laboratory   Investigations, Imaging  Studies,
                                    Therapeutic   interventions ,  Final  outcome , Follow  up
Inclusion   criteria :
? Patients  presenting   with    acute  onset  Flank   or  Loin pain ,  Fever
with  chills,  with  or  without   lower  urinary  tract  symptoms.
? Radiological   evidence  of   Renal   inflammatory     pathology.
Exclusion criteria :
? Patients   unwilling  to  undergo   intervention  as  a  part  of  therapy
Study   Protocol
? Diagnosis   of    renal    inflammatory   lesions    was   made   by
Complete   History (which   included  enquiry  on  predisposing   risk  factors ) ,
Clinical   Examination   and confirmed   by   imaging    studies.
39
Image 1 : CT Scan  of Patient Number 2 with Left   EPN
Image 2 : Isotope Study of  Patient Number 2 with  Left  EPN
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Image 3 : CT Scan of Patient Number 3 with Right Cortical Abscess
Image 4 : CT Scan  of Patient Number 4 with Bilateral EPN
? Patients  were    admitted   and   evaluated    with Urine   analysis , Urine
and  Blood culture  study,  Complete  Hemogram,Blood  sugar  and HbA1c
( In Diabetics) ,  Renal  Function   Tests, Liver    Function    Tests  ,  Blood
coagulation   profile  , relevant  additional  imaging  studies .
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Image 5 : CT Scan  of Patient Number 5 showing Left  Pyonephrosis
Image 6 : Patient Number 5 with Pyonephrosis Undergoing PCN
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? Managed   with
Hemodynamic   Support  ,  Fluid  and   electrolyte    management   ,  aggressive
sugar  control  in  diabetics  ,   and    antibiotics  ;   initially    with  broad
spectrum     parenteral  ( Injn. Cefotaxime   1gm   twice  daily )  then  changed
according  to     culture    &    sensitivity  report.
Image 7 : CT Scan of Patient Number 14 with  Perinephric abscess
                All   patients  were  initially  subjected   to  minimal  invasive
interventions  like  Percutaneous    Nephrostomy  (PCN)   drainage   under
ultrasonogram  guidance ,     Placement  of     Double   J  (DJ)   Stenting,    Both
percutaneous  nephrostomy  and   DJ  stenting ,   Image   guided  percutaneous
abscess   drainage   or   Open   Abscess  drainage  depending  on  the   type   of
lesion   diagnosed  with  the  intention  to  conserve  the  renal  unit.
           The    procedures   were    carried   out    after   obtaining     informed
consent ,  explaining  the  pros   and  cons   of  the  interventions  and   the  need
for  strict  followup   to  the  patient  and    relatives .
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Image 8 : Drainage of Perinephric abscess in Patient Number  14
            Patients  who  did  not  recover  with  the  medical  and  minimal
invasive  interventions   were  offered    additional  investigations  like
percutaneous  nephrostomy   fluid  analysis ,  follow up  CT  scan ,  radioisotope
scan   and   those   who  showed   clinical  deterioration  ,  increasing  renal
parameters    and  non  functional  status  in  isotope  scan  (  less  than  15%
split  renal  function )  were  subjected  to    Nephrectomy  after  obtaining
cardiac , anaesthetic  fitness and   correcting  any  coagulation  disorders if
present.
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Definitive  Treatment   of  Complicating  Factors were  also  carried  out  in the
patients  where  the  kidney  was  salvaged.
? Follow  up
Patient   were   followed   with   1  month    and    3   months   after   discharge.
Symptom    analysis ,  Clinical   Examination, Urine  Culture  & Sensitivity
Renal  Function  test  were  done  during  their  visit  and  those  patients  who
showed   recovery  were   included   in the  study.
? Data  collection   and  Statistical  analysis
Patients’ demographics, medical histories, clinical  parameters, biochemical and
laboratory variables, types  of   renal  lesions,  the  relevant therapeutic
interventions  and condition at discharge were   analysed   and     compared
among two  groups :
           Group I  --   Recovered  with Minimal Invasive  interventions (16 pts)
           Group II --   Required   Nephrectomy (14 pts)
Statistical   analysis   was  performed  with Statistical  Package for the Social
Sciences   (SPSS)   Version  15 software using  Pearson’s  Chi-Square   Test
and   Fisher's  Exact Test   with  P < 0.05  considered  to indicate  statistical
significance.
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OBSERVATIONS   AND   RESULTS
Total   number    of   Patients :   30
                             TABLE  1  :  AGE    STATISTICS
Minimum Maximum Mean Std.Deviation
Age in years 15 67 46.67 14.35
                            TABLE  2 :  AGE  WISE  DISTRIBUTION
Age Group Frequency
?  30      Years 6
31 – 50  Years 14
?  50       Years 10
                           CHART 1: AGE  WISE  DISTRIBUTION
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y
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                           TABLE  2 :  GENDER  DISTRIBUTION
Number  Percentage
FEMALE 20 66.7%
MALE 9 30.0%
TRANS  GENDER 1 3.3%
Total 30 100.0%
                            CHART 2 :  GENDER  DISTRIBUTION
                      TABLE  3  :    LATERALITY  OF  LESION
Number Percentage
BILATERAL 1 3.3 %
LEFT 16 53.3 %
RIGHT 13 43.3 %
Total 30 100.0 %
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                  CHART  3 :  LATERALITY   DISTRIBUTION
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                  TABLE  4  :  PREDISPOSING  RISK  FACTORS
FREQUENCY PERCENTAGE
DIABETES      MELLITUS 17 56.7 %
DM    &  UROLITHIASIS 8 26.7 %
LOWER TRACT  OBSTRUCTION 1 3.3 %
NEUROGENIC  DYSFUNCTION 1 3.3 %
PUJ  OBSTRUCTION 2 6.7 %
UROLITHIASIS 1 3.3 %
Total 30 100.0 %
178
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CHART  4   :   RISK FACTOR DISTRIBUTION
DIABETES
DM & UROLITHIASIS
LT OBSTRUCTION
NEUROGENIC
PUJ OBSTRN.
UROLITHIASIS
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POSITIVE   URINE  CULTURE
 Total    Number     :  21  ( 70%)
CHART 5 :  DISTRIBUTION OF  ORGANISMS  IN  URINE  CULTURE
POSITIVE   BLOOD  CULTURE
Total  Number  :   9 ( 30 %)
CHART  6 : DISTRIBUTION  OF ORGANISMS  IN  BLOOD CULTURE
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                   TABLE  5  :  TYPE  OF  LESION AT  PRESENTATION
                                              (  Based  on   Imaging   Studies )
Frequency Percentage
BILATERAL  . EPN 1 3.3 %
EPN 14 46.7 %
PERINEPHRIC ABSCESS 2 6.7 %
PYONEPHROSIS 10 33.3 %
RENAL ABSCESS 3 10.0 %
Total 30 100.0 %
                    CHART   7: DISTRIBUTION OF TYPE  OF  LESION
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                     TABLE  6:  THERAPEUTIC   INTERVENTIONS
MANAGMEMENT  NUMBERS (%) REQUIRED
NEPHRECTOMY
MEDICAL
MANAGEMENT
2 /30 (6.6%) NIL
PERCUTANEOUS
NEPHROSTOMY (PCN)
12/30 (46%) 11
DJ  STENTING 7 /30   (23.3%) NIL
PCD &  DJ   STENTING    4 /30   (13.33%)                 1
OPEN  DRAINAGE 3 / 30  (10%) 2
IMAGE GUIDED
ASPIRATION
   1 / 30  ( 3.3 %)               NIL
                     CHART 8 :   THERAPEUTIC  INTERVENTIONS
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            CHART  9  :  NEPHRECTOMY  AND  TYPE  OF   LESION
9
4
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EPN
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The      collected    data    on     the    various    demographic  ,   clinical   ,
biochemical , imaging  variables   were  compared  between   both  the  groups
to  derive  out  those   factors  that  had  significant  association  with
occurrence  of   nephrectomy   implying  poorer  outcome  of  the  disease
process.
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STATISTICAL  ANALYSIS
       TABLE  7  :   CORRELATION   OF   AGE-GROUP   WITH  OCCURRENCE
                                                                 OF   NEPHRECTOMY
                                                                      Cross tab
           NEPHRECTOMY
NO YES Total
AGE
GROUP
1
( ? 30 Yrs )
Count 2 4 6
% of Total 6.7% 13.3% 20.0%
2
(31 -50  Yrs )
Count 7 7 14
% of Total 23.3% 23.3% 46.7%
3
( > 50 Yrs )
Count 7 3 10
% of Total 23.3% 10.0% 33.3%
Total Count 16 14 30
% of Total 53.3% 46.7% 100.0%
                                                        Chi-Square Tests
Value df Asymp. Sig. (2-sided)
Pearson Chi-Square 2.143a 2 .343
Likelihood Ratio 2.192 2 .334
No. of Valid Cases 30
a. 3 cells (50.0%) have expected count less than 5. The minimum expected count is 2.80.
     CHI  SQUARE :  2.143    P =  0.343     NOT  SIGNIFICANT
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     TABLE  8  :   CORRELATION     OF   GENDER     WITH  OCCURRENCE
                                                       OF    NEPHRECTOMY
Crosstab
                                                     Count
SEX Total
FEMALE MALE TG
NEPHRECTOMY
NO 11 4 1 16
YES 9 5 0 14
Total 20 9 1 30
                                              Chi-Square Tests
Value df Asymp. Sig. (2-sided)
Pearson Chi-Square 1.183(a) 2 .553
Likelihood Ratio 1.565 2 .457
No. of Valid Cases 30
(a) 4 cells (66.7%) have expected count less than 5. The minimum expected
count is .47.
CHI  SQUARE :  1.183   P =  0.553   NOT  SIGNIFICANT
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TABLE 9  :  CORRELATION    OF   LATERALITY   OF   LESION   WITH
                                             OCCURRENCE   OF    NEPHRECTOMY
                                                      Crosstab
                                                        Count
LATERALITY OF   LESION Total
BILATERAL LEFT RIGHT
NEPHRECTOMY
NO 1 8 7 16
YES 0 8 6 14
Total 1 16 13 30
Chi-Square Tests
Value df Asymp. Sig. (2-sided)
Pearson Chi-Square .948(a) 2 .623
Likelihood Ratio 1.330 2 .514
No. of Valid Cases 30
(a) 2 cells (33.3%) have expected count less than 5. The minimum expected count is .47.
CHI  SQUARE :  .948   P =  0.623   NOT  SIGNIFICANT
        TABLE  10 : CORRELATION   OF   PREDISPOSING  RISK  FACTOR   WITH
                                                  OCCURRENCE  OF   NEPHRECTOMY
                                                                                  Crosstab
                                                                                   Count
                                               PREDISPOSING      RISK   FACTORS Total
DIABETES DIABETES&UROLITHIASIS
LOWER
TRACT
OBSTRUCTION
NEU
ROG
ENIC
PUJO
UROLI
THIASI
S
NEPHRECTOMY
NO 13 2 1 0 0 0 16
YES 4 6 0 1 2 1 14
Total 17 8 1 1 2 1 30
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                                                   Chi-Square Tests
Value df Asymp. Sig. (2-sided)
Pearson Chi-Square 11.683(a) 5 .039
Likelihood Ratio 13.908 5 .016
No. of Valid Cases 30
(a) 10 cells (83.3%) have expected count less than 5. The minimum expected count is .47.
CHI  SQUARE : 11.683   P =  0.039    SIGNIFICANT
  TABLE  11:CORRELATION   OF  ALTERED  SENSORIUM AT PRESENTATION
                                           WITH  OCCURRENCE  OF   NEPHRECTOMY
                                                       Crosstab
                                                         Count
          ALTERED SENSORIUM Total
NO YES
NEPHRECTOMY
NO 16 0 16
YES 6 8 14
Total 22 8 30
                                                               Chi-Square Tests
Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided)
Pearson Chi-Square 12.468(b) 1 .000
Continuity Correction(a) 9.717 1 .002
Likelihood Ratio 15.673 1 .000
Fisher's Exact Test .001 .001
No. of Valid Cases 30
(a) Computed only for a 2x2 table
(b) 2 cells (50.0%) have expected count less than 5. The minimum expected count is 3.73.
CHI  SQUARE : 12.468    P< 0.001    SIGNIFICANT
56
    TABLE  12  :  CORRELATION  OF HYPOTENSION ( SYSTOLIC BP < 90mm Hg )
                     AT  PRESENTATION  WITH   OCCURRENCE   OF   NEPHRECTOMY
Crosstab
Count
HYPOTENSION Total
NO YES
NEPHRECTOMY
NO 13 3 16
YES 8 6 14
Total 21 9 30
                                                                Chi-Square Tests
Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided)
Pearson Chi-Square 2.066(b) 1 .151
Continuity Correction(a) 1.078 1 .299
Likelihood Ratio 2.088 1 .148
Fisher's Exact Test .236 .150
No. of Valid Cases 30
(a) Computed only for a 2x2 table
(b) 2 cells (50.0%) have expected count less than 5. The minimum expected count is 4.20.
    FISHER’S   EXACT  TEST    P = .236          NOT   SIGNIFICANT
TABLE  13  : CORRELATION   OF  POOR  GLYCEMIC  CONTROL ( HbA1c >  7)
                                         WITH   OCCURRENCE   OF     NEPHRECTOMY
Crosstab
Count
INC.HbA1C Total
NO YES
NEPHRECTOMY
NO 12 4 16
YES 5 9 14
Total 17 13 30
57
                                                                  Chi-Square Tests
Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided)
Pearson Chi-Square 4.693(b) 1 .030
Continuity Correction(a) 3.229 1 .072
Likelihood Ratio 4.810 1 .028
Fisher's Exact Test .063 .035
No. of Valid Cases 30
(a) Computed only for a 2x2 table
(b) 0 cells (.0%) have expected count less than 5. The minimum expected count is 6.07.
CHI  SQUARE : 4.693   P =  0.030    SIGNIFICANT
TABLE 14  : CORRELATION  OF  LEUCOCYTOSIS
( WBC  Count  > 15,000 /cu.mm )
WITH  OCCURRENCE  OF    NEPHRECTOMY
                                                           Crosstab
                                                             Count
LEUCOCYTOSIS Total
NO YES
NEPHRECTOMY
NO 6 10 16
YES 8 6 14
Total 14 16 30
                                                                     Chi-Square Tests
Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided)
Pearson Chi-Square 1.158(b) 1 .282
Continuity Correction(a) .503 1 .478
Likelihood Ratio 1.164 1 .281
Fisher's Exact Test .464 .240
No. of Valid Cases 30
(a) Computed only for a 2x2 table
(b) 0 cells (.0%) have expected count less than 5. The minimum expected count is 6.53.
    FISHER’S  EXACT  TEST      P = .464     NOT   SIGNIFICANT
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TABLE  15  :    CORRELATION  OF  THROMBOCYTOPENIA
(Platelets < 1,00,000/cu.mm)WITH   OCCURRENCE    OF   NEPHRECTOMY
                                                           Crosstab
                                                             Count
THROMBOCYTOPENIA Total
NO YES
NEPHRECTOMY
NO 16 0 16
YES 3 11 14
Total 19 11 30
                                                           Chi-Square Tests
Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided)
Pearson Chi-Square 19.850(b) 1 .000
Continuity Correction(a) 16.610 1 .000
Likelihood Ratio 24.881 1 .000
Fisher's Exact Test .000 .000
No. of Valid Cases 30
(a) Computed only for a 2x2 table
(b) 0 cells (.0%) have expected count less than 5. The minimum expected count is 5.13.
FISHER’S  EXACT  TEST      P < 0.001    SIGNIFICANT
TABLE  16 : CORRELATION    OF   INCREASED  SERUM  CREATININE
(Sr. Creatinine  > 2 mg /dl) WITH  OCCURRENCE OF  NEPHRECTOMY
Crosstab
Count
INCREASED
SERUM CREATININE Total
NO YES NO
NEPHRECTOMY
NO 9 7 16
YES 0 14 14
Total 9 21 30
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                                                                        Chi-Square Tests
Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided)
Pearson Chi-Square 11.250(b) 1 .001
Continuity Correction(a) 8.731 1 .003
Likelihood Ratio 14.722 1 .000
Fisher's Exact Test .001 .001
No. of Valid Cases 30
(a) Computed only for a 2x2 table
(b) 2 cells (50.0%) have expected count less than 5. The minimum expected count is 4.20.
FISHER’S  EXACT  TEST      P = .001       SIGNIFICANT
TABLE  17:  CORRELATION   OF  POSITIVE  URINE CULTURE
WITH   OCCURRENCE  OF  NEPHRECTOMY
                                                   Crosstab
                                                     Count
       URINE CULTURE
              POSITIVE Total
NO YES
NEPHRECTOMY
NO 3 13 16
YES 6 8 14
Total 9 21 30
                                                                  Chi-Square Tests
Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided)
Pearson Chi-Square 2.066(b) 1 .151
Continuity Correction(a) 1.078 1 .299
Likelihood Ratio 2.088 1 .148
Fisher's Exact Test .236 .150
No. of Valid Cases 30
(a) Computed only for a 2x2 table
(b) 2 cells (50.0%) have expected count less than 5. The minimum expected count is 4.20.
 FISHER’S  EXACT  TEST      P = .236     NOT   SIGNIFICANT
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TABLE  18 :  CORRELATION  OF  POSITIVE   BLOOD CULTURE
WITH  OCCURRENCE  OF   NEPHRECTOMY
                                                 Crosstab
                                                   Count
          BLOOD CULTURE
                 POSITIVE Total
NO YES
NEPHRECTOMY
NO 13 3 16
YES 8 6 14
Total 21 9 30
Chi-Square Tests
Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided)
Pearson Chi-Square 2.066(b) 1 .151
Continuity Correction(a) 1.078 1 .299
Likelihood Ratio 2.088 1 .148
Fisher's Exact Test .236 .150
No. of Valid Cases 30
(a) Computed only for a 2x2 table
(b) 2 cells (50.0%) have expected count less than 5. The minimum expected count is 4.20.
    FISHER’S  EXACT  TEST      P = .236     NOT   SIGNIFICANT
     TABLE  19  :  CORRELATION    OF    PRESENCE   OF     HYDRONEPHROSIS
                                               WITH   OCCURRENCE  OF    NEPHRECTOMY
                                                 Crosstab
Count
HYDRONEPHROSIS + Total
NO YES
NEPHRECTOMY
NO 12 4 16
YES 2 12 14
Total 14 16 30
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                                                                   Chi-Square Tests
Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided)
Pearson Chi-Square 11.059(b) 1 .001
Continuity Correction(a) 8.754 1 .003
Likelihood Ratio 11.977 1 .001
Fisher's Exact Test .001 .001
No. of Valid Cases 30
(a) Computed only for a 2x2 table
(b) 0 cells (.0%) have expected count less than 5. The minimum expected count is 6.53.
FISHER’S  EXACT  TEST      P = .001       SIGNIFICANT
                             TABLE  20  :   CORRELATION   OF   TYPE  OF  LESION
                                                    WITH   OCCURRENCE  OF   NEPHRECTOMY
                                                                                Crosstab
                                                                                 Count
TYPE OF LESION Total
BIL.EPN EPN PERINEPHRICABSCESS PYONEPHROSIS
RENAL
ABSCESS
NEPHRECTOMY
NO 1 10 1 1 3 16
YES 0 4 1 9 0 14
Total 1 14 2 10 3 30
                                                Chi-Square Tests
Value df Asymp. Sig. (2-sided)
Pearson Chi-Square 12.895(a) 4 .012
Likelihood Ratio 15.430 4 .004
No. of Valid Cases 30
(a) 7 cells (70.0%) have expected count less than 5. The minimum expected count is .47.
CHI  SQUARE : 12.895    P =  0.012      SIGNIFICANT
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TABLE  21 : ASSOCIATION  OF  FACTORS  WITH  NEPHRECTOMY
                           (DEMOGRAPHIC   AND   CLINICAL VARIABLES)
TOTAL
NUMBER
OF CASES
GROUP I
RENAL
SALVAGE
GROUP II
NEPHRECTO
MY
‘P’
VALUE
SIGNIFICANCE
AGE
GROUP   I
GROUP  II
GROUP III
  6
14
10
     2
     7
     7
       4
       7
       3
0.343            NOT
SIGNIFICANT
GENDER
MALE
FEMALE
TRANSGENDER
  9
20
  1
      4
    11
      1
      5
      9
      0
0.553           NOT
SIGNIFICANT
LATERALITY
RIGHT
LEFT
BILATERAL
13
16
  1
     7
     8
     1
     6
     8
     0
0.623
          NOT
SIGNIFICANT
RISK FACTORS
1 DIABETES
2.DM&
   UROLITHIASIS
3 LOWER TRACT
    OBSTRUCTION
 4.NEUROGENIC
     DYSFUNCTION
 5. PUJ
     OBSTRUCTION
6. UROLITHIASIS
  17
    8
    1
    1
    2
    1
    13
      2
      1
      0
      0
      0
      4
      6
      0
      1
      2
      1
0.039   SIGNIFICANT
ALTERED
SENSORIUM
    8       0       8 < 0.001 SIGNIFICANT
HYPOTENSION     9       3       6 0.236          NOT
SIGNIFICANT
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TABLE  8 : ASSOCIATION  OF  FACTORS WITH NEPHRECTOMY
                 ( LABARATORY  AND  RADIOLOGICAL VARIABLES)
  TOTAL
NUMBER
    OF
CASES
   GROUP I
     RENAL
SALVAGE
     GROUP II
 NEPHRECTOMY
    ‘P’
VALUE SIGNIFICANCE
INCREASED
HBA1c
     13        4             9    0.030 SIGNIFICANT
LEUCOCYTOSIS     16      10              6    0.464           NOT
SIGNIFICANT
THROMBO-
CYTOPENIA
     11        0            11   < 0.001   SIGNIFICANT
INCREASED  SERUM
CREATININE
     21        7            14      0.001   SIGNIFICANT
POSITIVE
URINE CULTURE
     21       13              8     0.236           NOT
SIGNIFICANT
POSITIVE
BLOOD  CULTURE
       9       3              6     0.236           NOT
SIGNIFICANT
PRESENCE  OF
HYDRONEPHROSIS      16       4            12     0.001
SIGNIFICANT
TYPE  OF  LESION
PYONEPHROSIS
EPN
BILATERAL  EPN
PERINEPHRIC-
ABSCESS
CORTICAL –
ABSCESS
      10
      14
         1
         2
         3
       1
     10
       1
       1
       3
              9
              4
              0
              1
              0
    0.012
SIGNIFICANT
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ANALYSIS  AND  DISCUSSION
Inflammatory  lesions  of  kidney  commonly  encountered    in  urological
practice    are      secondary   to   infectious    processs    although    a  variety  of
immunologic, congenital, metabolic   or toxin   induced  diseases     can  present
as   renal   inflammation.  The   inflammatory   process   may   be   acute   usually
following  a   bacterial   infection ( Bacterial nephritis )  and   includes
spectrum of clinical entities, progressing  from mild   acute   pyelonephritis   to
renal abscesses or emphysematous  pyelonephritis. Inflammation  as  a  chronic
process      occur    as   a    consequence  of   either    infection  superadded   on
structural  and  functional  abnormalities    such  as   vesicoureteral   reflux
disease  or  reactivation  of   latent   infection  with  organisms   like
Mycobacterium   tuberculosis.  There  are   no  specific  symptoms  for   chronic
pyelonephritis   until   it   produces   renal   insufficiency, and  then  the
symptoms   are    similar   to   those   of   any  other  form of chronic renal
failure.
                    The    severity  of   the  renal  infection  depends   on  the  virulence
factors   of     the   offending    agent   and   the   strength   of    host   defence
mechanisms.     We   conducted   this    study  to  analyse   the   host   factors
that  influences   the   clinical  course  and  the   final   outcome   of    acute
inflammatory  pathology.
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We  included  in  the  study  patients  who  were  admitted   with  symptoms
suggestive  of    acute   renal  inflammation  which  included   presence  of  loin
or  flank  pain  of   short  duration ,  fever with  chills   with  or  with   out  lower
urinary   tract   symptoms     and    whose    imaging   studies    revealed   the
presence  of    inflammation  either  in the  renal  parenchyma  or  collecting
system.
                    37  patients    fulfilled  the  inclusion  criteria  but   among  them  4
patients   who  had  recurrence  of  the  disease  in  the  followup   period   and
3  patients   who  did  not  attend  the  followup  clinics  were   excluded   from
the  study  and   hence  the  data   from  30  patients  were   taken  up   for  the
statistical    analysis.
                  In  our  study   the  mean  age   of   the  patients  was   46.67  years
and     minimum   and   maximum   ages    were    15  years    and   67  years
respectively.    Female    out  -  numbered   male   (  20  :   9  )  .   There   was   one
transgender  patient  ( patient  number  14   in  chart)   who  was  admitted  with
right  perinephric  abscess  consequent  to   urethral  stenosis  following   the
sex  realignment  surgery.
              The  renal   lesions  were   more  common  in   the  left   side  in   our
study  than  right  (  16 : 13) . One  of  the  patient  (  patient  number  4  in
chart)  had  bilateral  presentation  of   emphysematous   pyelonephritis.
                    The  predominant    risk  factor  leading  to  the  complicated  renal
infections  in  our   study   was   the   presence  of   diabetes  ( 17  patients ;
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56.7%) .  Concomitant   diabetes   and   urinary  stones    were   present   in   8
patients  ( 26.7% )  most  of  them  landing up  with  pyonephrosis.  Upper  tract
abnormality  in  the  form  of  pelvi-ureteric   junction  obstruction  was   seen
in  2  patients  ( 6.7%) . Presence  of  lower  urinary  tract   obstruction   in   the
form  of  urethral  stenosis,  neurogenic  bladder  dysfunction  with
vesicoureteric  reflux  and  non obstructive  renal stone  were   also  noted  as
predisposing  risk  factor  in  our  patients .
                      The   patients   were   grouped   into   two   for   the   purpose   of
analysing   the    statistical    analysis    of    the    collected   data   .  Group  I
(16   in   number)     were    the   patients    whose   affected   renal   unit    were
conserved  by  medical   and  minimally  invasive  surgical   interventions.
Group  II  comprising   patients   (  14  in  number )  where   there  was
deterioration  of   clinical  condition  inspite  of   these  interventions
warranting   nephrectomy   to  avoid  mortality.
                 Mortality   in  our  study  occurred   in  3  patients  ( 10%). One
patient   with   Class  III  (  Huang   and   Tseng  et  al [42]) emphysematous
pyelonephritis  ( patient  number  6  in chart )  and  another  patient  with
pyonephrosis  ( patient  number  27  in  chart)   expired   following
nephrectomy   in  the  immediate  post operative   period  due  to   acute
respiratory  distress  syndrome (ARDS ) .Another   patient  (  patient  number
26   in  chart )  who  had  nephrectomy   for   emphysematous  pyelonephritis
expired   due  to  myocardial   infarction  in  the  followup   period .
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            The   various     demographic ,  clinical  , biochemical , imaging
variables were  compared  between   both  the  groups   to  derive  out  those
factors  that  had  significant  association  with  occurrence  of   nephrectomy
implying  poorer  outcome  of  the  disease   process.
              The   patients  were  categorised  in  to  3  groups  according  to  their
age  ; Group I   ? 30 years ( 6 patients)  , Group II   31 – 50 years ( 14 patients )
and  Group III    ? 50  years  ( 10 patients)  for  statistical  analysis. Age  Group
did   not   have   any   significant   association   with   the   occurrence   of
nephrectomy   ( P value  of  0.343 ) (Table. 7)
           Although   females  formed    the  predominant  gender  group    in  our
study  (   16   patients)   ,   the   gender   of   the   patient   showed   no    statistical
significance  with   the   nephrectomy  ( P value    of   0.553) (Table. 8)
           Left  sided  lesions  were  more  common  in  our  study  ( 16 patients )
but   the  side  of  the  lesion  did   not  have  any  influence  in  the   progression
of  the  disease  to  terminate  in   nephrectomy .  Test  of  significance  showed
a  P value  of  0.623 (Table. 9) which  was  not  statistically  significant.
                Diabetes   was  the  predominant    predisposing  risk  factor   in   our
patients  in the  study    ( totally  25 patients  with  8   of  the  patients  had
concomitant  urolithiasis )  .  This   was  in  concordance  to  the  various
studies available   which  highlight  the  role  of  diabetes  in  upper  tract
infections.  Studies   by  Muller et al [31]   and  Joshi   et   al [32]  showed  that
diabetes   may  predispose   patients   to  more    severe    infections    and
68
complications   of   the upper  urinary  tract  with  its  inherent  capacity  to
reduce  the  host  immune  response.   Hoepelman  et  al [33]  and     Patterson  et
al [34]  in their  studies  emphasised   the  fact  that  infections  in   diabetics   are
more  difficult  to  treat  and  tend  to  recur  often.  Some   studies  showed  that
diabetes   increases  the  risk  of   hospitalization  and  mortality  from
infections. [35,36] Only   4    of   the  17   patients   in  the   diabetes   alone   group
progressed  to  nephrectomy  (  23.5%)   but  6  out  of  the  8  patients  ( 75 %)
in  the  concomitant  diabetes  and  urolithiasis  group  had  severe  disease
process  progressing  to  nephrectomy. This  constitutes  the  reason  for
significant    statistical   association  of  the    type   of  inflammatory  lesion  in
our   study  to  nephrectomy  occurrence ( P value  of 0.039). (Table. 10)
        Two  important  clinical  presentation   at  the  time  of  admission;  altered
mental  status   and  the  presence  of   hemodynamic  instability  were
analysed  in  our  study  to  derive  out  their  influence  in   the   occurrence   of
nephrectomy.
            Altered  sensorium  evidenced   by  the  presence   of   mental confusion,
disorientation  and  stupor   was  observed  in  8  of  our  patients ( 26.66%)   as
they  presented   with   overwhelming  sepsis  at  the  time  of  admission.
Although  all  these  patients   recovered  their  sensorium  following
resuscitation ,  antibiotics    and  minimal   invasive  procedures   their  renal
units   were   grossly   tampered   by   the   disease   process   and   all    these   8
patients  (100% )   landed  up  with  nephrectomy .In  statistical   analysis   there
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was   significant   statistical   association  with   altered  sensorium  at  clinical
presentation   and  nephrectomy  ( P  value  of  <0.001) (Table. 11) confirming
it   as   one   of   the   important   prognostic   factor   influencing     outcome  of
complicated   renal  infections .
               Hemodynamic  instability   as  evidenced  by  hypotension  with
systolic  pressure  of  less  than  90 mm  Hg  was  present in  9 of  the  patients
(30 %)  in our  study.  These  patients    required  resuscitation  with the  use  of
intravenous  fluids   and  administration  of  ionotropic  agents . 6  of  the
patients (66.6% )   had  nephrectomy  as  their  final  treatment  outcome  and
the  statistical  analysis     showed  no  statistical  association  between   the
presence  of  hypotension  at  clinical  presentation   and  nephrectomy .  P value
in  the  test of  significance  was  0.236  which  was  not  significant. (Table. 12)
Efstathiou  et  al.[37] in  their   study  on   predictors   of  poor  treatment
outcome  of  complicated  pyelonephritis  showed  that   age  >  65  years ,
septic  shock  and  bedridden  status  had   greater  risk  of  death . Our  study
revealed  altered  sensorium  but  not  presence  of    hemodynamic  stability  as
one  of  the   factors  predicting   poor  outcome .
               The    laboratary    biochemical    parameters  of  HbA1c ( glycosylated
haemoglobin ), total  white  blood  cell count,  serum  creatinine   level  ,blood
platelet  levels  , urine  and  blood  culture    of  the   patients  were   analysed
between  the   two   groups  to  determine   their  predicting    ability  for  the
occurrence  of   nephrectomy.
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                     HbA1c   level  in  the  blood  reflects  the  adequacy  of  control  of
diabetes  with  normal  value  of  7  indicating  good  glycemic   control. HbA1c
levels   were  checked   in  all of  our   diabetic  patients   ( 25  in  number) .
Increased  HbA1c  ( value  of  >  7 )  was   present  in  13  of  the  25 patients
(52%).    9   among   them   had   the   occurrence   of   nephrectomy   as   their
terminal  event ( 69%) . Statistical   analysis   revealed   significant  statistical
association   with   the  P value   of   0.030. (Table. 13) Although   previously
suggested  as  possible   risk   factors, duration  of   diabetes  or   elevated
HbA1c levels have   not   been   shown  to  increase   the   risk   of   UTI   in
recent   studies.  by   Geerlings  et  al. [38]   and    Boyko   et  al. [39]
                   Leucocytosis    is  a  frequent  accompaniment  in  acute  infectious
process .  A   white  blood  cell   count  more  than   15,000 / cubic millimeter
was  considered    as   leucocytosis   in  our  study  and  it  was  present  in  16
patients  (53.33%)  . Statistical  analysis    showed  no  significant  association
between   the    presence   of   leucocytosis     and    nephrectomy    occurrence
( P value  of 0.464 )  (Table. 14)
                 Infection   can    induce  secondary  immune  mediated  destruction
of  platelets   and  because  of  the  short  life  span  the   platelet  reserves  get
exhausted  in  a  quicker  time  to  result  in  significant   thrombocytopenia.  We
had  count   of    platelets  less  than  1,00,000 / cubic millimeter  as   defining
criteria  of  thrombocytopenia   in  our  study  . This  was  present  in   11
patients  (36.6%)  and   all   had  nephrectomy  (100%).  Statistical  analysis
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showed  significant   statistical  association  with  occurrence  of  nephrectomy
with   the   P   value   of   <  0.001.  (Table.  15)Thrombocytopenia    has    been
considered   as  a  significant  poor   prognostic  factor   for   emphysematous
pyelonephritis  in  various  studies  by   Falagas et al. [40]    and    Wan  et al. [41]
             Raised  serum  creatinine   level    ( >  2 mg / deciliter )  at  initial
presentation   was  present  in  21 of  the  patients  (70% )  reflecting  the
severity  of  the  infection .  Among   these  patients  14  (66.6%)   landed  up
with  nephrectomy .  Stastistical   analysis   showed   significant   association
between  the  raised   creatinine  level   and  nephrectomy  (P value  =0.001)
(Table. 16) implicating  the  fact  that   patient  with  acute  renal  insufficiency
had  more  protracted  disease  outcome .  Falagas   et  al [40]    showed   in  his
study   that  raised  serum  creatinine  ( 2.5mg /dl )   at  the  time  of
presentation is  associated  with   poor  prognosis  increasing  mortality  in
emphysematous  pyelonephritis.
        Urine   culture  was  positive  in  21  patients  (70%)  in  our  study  but
there  was  no  statistical  association  of  this   variable   among  the
nephrectomy   group  (P value  = 0.236). (Table. 17) Blood   culture   was
positive  in  a  lesser  number  of  patients;  only   9   patients  (  30% )  had
significant  bacteremia  but  statistical  analysis   failed  to  show   any
significant  association  between  bacteremia   and   nephrectomy. (Table. 18)
Prior   antibiotic  usage  accounted   for   significant  number  of  patients
having  negative  culture.
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                    Presence   of   hydronephrosis  and  the   type  of   presenting
inflammatory  lesion  in  the  imaging   studies  were   analysed  to    probe  their
association  with   the  need  of   nephrectomy  in  our  study .
           Hydronephrosis  of   varying  degrees    was   apparent  in  16  patients
( 53.33%)  ; 10  among  them  was  associated  with   pyonephrosis   and  6  with
emphysematous  pyelonephritis . 12  of  these  patients  had  to  be  performed
with  nephrectomy  following   failure   of  initial  percutaneous   nephrostomy
drainage  as   the  PCN  fluid  analysis  and  radio isotope  scan  revealed  non
functioning  renal  moiety.  Statistical  analysis    showed   significant
association  between  the  presence   of   hydronephrosis   and  nephrectomy
procedure  with  test  of  significance   P value   being  0.001. (Table. 19)
           Presenting   lesion  type  greatly  influence   the  therapeutic  option
excised  on  the  patient .  Nephrectomy  was  inevitable   in  9  patients  with
pyonephrosis   (  30%)   and   4  patients    of   severe   emphysematous
pyelonephritis   which  belong   to   class III  of Huang  and  Tseng et al.  CT
classification [42]  and  these  lesions  formed  the  major  bulk  of   nephrectomy
in  our  study. Group  statistics  rightly  showed  significant  association
between  the  type  of   presenting   lesion  and  the  need  for   nephrectomy
with  the  P  value  being   0.012. (Table. 20)
                   In  the   study  conducted   by  Kapoor  et  al[43]  on  predictive
factors  for  the  need   of   nephrectomy  in  emphysematous  pyelonephritis
cases,    extensive    renal    parenchymal   destruction   of     50% (  based  on
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computed tomography)  significantly   predicted  the  need  for   nephrectomy .
Presence  of   hydronephrosis    nor   Huang  and  Tseng et al.  CT scan
classification [42]  of  EPN cases    did   not   have  significant   association   in
their   study  .  Our  study   had   higher  number   of   pyonephrotic   lesions
landing     up   with   nephrectomy  and    hence   the    reason   for    significant
association  of   presence   of    hydronephrosis   and   type  of   lesion   with
nephrectomy .
Limitations   of  our   Study
There    are   few   limitations   considering   the   outcome   of  this   study
? Our    study   may   not   be   representative   of   the   general   population    in
view   of  the  small  cohort   and   short  duration  of  the  study
? Our  hospital  being  a tertiary  institute  , the    cohort  consisted    more  of
complicated   cases  referred  from  other  places   which  resulted  in
skewing  of  increased   nephrectomy  rates  (40%)
? Followup  period   in  our  study  is  short  (up  to  3 months ) and  a  lengthier
followup  is  necessary  inorder  to  give  a  more  predictable   outcome.
74
CONCLUSION
? Diabetes   is  the  most  common  predisposing  risk  factor  for  the
occurrence  of   acute  inflammatory   lesion  of   kidneys    in  our   study .
? Concomitant   presence   of  diabetes   and   urolithiasis  confers  higher
incidence  of   severe  renal  parenchymal  damage  leading  to  nephrectomy
? The  presence  of  an  altered  mental  status  at presentation  ,poor glycemic
control  (  increased  HbA1c  levels ) , increased  serum  creatinine ,
thrombocytopenia  and    presence   of   hydronephrosis  at   presentation
are   associated   with  higher  need    for  nephrectomy   in   our   study
? Type  of   renal   lesion  at   presentation  significantly   influence   the
therapeutic  option  excised  and  the  need   for  performing   nephrectomy.
? Our   study   shows     no   significant   association   with    age,   gender
,laterality  of   lesion  , haemodynamic   instability  at  presentation ,
leukocytosis,  positive  urine  culture   and   bacteraemia   with  the
occurrence of  nephrectomy.
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ANNEXURE III - Copy of Informed Consent
I ________________________ willing  to   participate  in   the   study  titled
‘ STUDY    ON     FACTORS   INFLUENCING    THE    COURSE   AND
  OUTCOME      OF     INFLAMMATORY      LESIONS    OF    KIDNEY
                                                    IN   ADULTS .’
          I   am   aware  that   I  will   be   undergoing   various   tests  to  study  my
kidney   function. I   am   willing  to   undergo   any   medical  and  surgical
intervention to  treat   my  ailment. I  am aware  that   a  tube may  be placed in
my   affected   kidney  to assess  whether   it   is   advisable  to repair  the  block.
         The   final  decision   to remove   affected   kidney   or   repair   it ,will be
based  on   the   results.  The   complications   and   other   details    have    been
extensively   discussed    with   me. The   purpose   and    the   advantage  of
the    study   has   been  explained   in   the   mother   tongue   by   the
investigator. I   am   also  aware   that   I   can   discontinue   from   the   study
whenever   I   wished   to   do  so.
Date:
Place:
                                                                           Signature of the Patient/Guardian
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ANNEXURE IV - COPY OF PROFORMA
                  INFLAMMATORY   LESIONS   OF     KIDNEY
Name -                                    Age/Sex:                     IP.No-                 D.O.A
Address-                                                                                                 D.O.D
COMPLAINTS :
PRESENT   H/0 :
PAST   H/O –      Complicating      factors
Intubated   Urinary   tract :          Indwelling   catheters  --
                                                         Internal   Stents --  Ureteral   or   Urethral
Obstruction :          Upper Tract  /  Lower Tract                Treatment ( if  any )
Childhood    Infections  :
Diabetes mellitus:      Period :                       Treatment :   OHA  /  Insulin
                                     Presence   of   Ketosis:
Immunosuppression: HIV:                          TB:
                                                                 Use  of  steroids:
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Urolithiasis :                            Site:                             Intervention :
                                                  Clearance:
Surgery  of  the  urinary  tract:
Functional and anatomical abnormalities of the urinary tract
Voiding dysfunction /  Neurogenic :
EXAMINATION :    G/E:                                         Temp:                       PR:
                                    BP:             Mental  Status :
P/A:
External  Genitals:
PR:
CLINICAL   DIAGNOSIS:
INVESTIGATIONS :
Urine   Routine Alb:                         Sugar:                         Deposits:
                                       Ketones:
Urine   Culture & Sensitivity   :
86
Blood  Hb   :                    TC:                      DC:                                ESR:
Platelet:
Coagulation  Profile :
Blood   Sugar:                       HbA1c :                          Blood  Urea:
Sr . Creatinine:                                  Sr . Electrolytes :
Blood  Culture  & Sensitivity :
X ray    KUB:
USG    KUB:
IVU:
CT       KUB :
Chest  X  Ray  :
ECG :              :
Blood   Grouping & Typing:
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Renal   isotope   study  :                     DTPA   /  DMSA
COMPLICATIONS:
PLAN –
Medical  Treatment:
Blood  Transfusion ( if any):
Surgical    Procedure     done : STENTING  /    PCN  / Open Drainage   /
                                                          NEPHRECTOMY  /   OTHERS
Post Operative Complications :
Post  Operative  Biochemistry  &  Imaging (  if  any ):
Follow up:
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                                                  ANNEXURE  V – MASTER CHART
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1. Mrs. Amsavalli 61 Female 2834 4.1.12 KMCH Diabetes NO NO E.coli 10.2 16,700 P78,L20,E2 2,50,000 212 8 58 2.8 No Growth Lt. EmphysematousPyelonephritis YES
Lt.Percutaneous
Nephrostomy?
Lt.DJ Stenting
NO NO
2. Mrs. Mallika 62 Female 4122 20.2.12 KMCH Diabetes YES YES E.coli 9.3 12,200 P65,L32,E3 80,000 256 9.2 48 2.9 E.coli Lt. EmphysematousPyelonephritis YES
Lt.Percutaneous
Nephrostomy YES NO
3. Mrs. Mohana 36 Female 8472 2.4.12 KMCH Diabetes NO NO No Growth 11.2 11,500 P66,L33,E1 2,75,000 187 6.3 23 1.1 No Growth Rt. Renal CorticalAbscess NO Medical Management NO NO
4. Mrs.Sundari 49 Female 996609 11.4.12 GRH Diabetes NO NO Pseudomonas 9.4 17,200 P82,L17,E1 1,85,000 235 8.2 57 2.7 E.coli
Bilateral
Emphysematous
Pyelonephritis
NO Bilateral DJ Stenting NO NO
5. Ms. Meena 15 Female 10497 20.4.12 KMCH PUJ obstruction NO NO No Growth 11 16,900 P78,L21,E1 2,85,000 98 - 45 2.6 No Growth Lt. Pyonephrosis YES Lt.  Percutaneous Nephrostomy YES NO
6. Mr.Murali 42 Male 996909 2.5.12 GRH Diabetes YES NO Klebsiella 10.3 18,200 P75,L23,E2 79,000 220 7.9 50 2.5 No Growth Lt. EmphysematousPyelonephritis NO Lt.Open Drainage YES YES
7. Mr. Pavadai 56 Male 11961 3.5.12 KMCH Diabetes NO NO Proteus 11.8 17,500 P72,L26,E2 1,80,000 149 5.3 27 1.2 Klebsiella Lt.EmphysematousPyelonephritis NO Lt. DJ Stenting NO NO
8. Mr.Sajid Khan 64 Male 9261 5.5.12 KMCH Diabetes NO YES E.coli 12 8,700 P66,L33,E1 2,75,000 153 6.1 30 1.1 No Growth Rt.EmphysematousPyelonephritis YES Rt. DJ Stenting NO NO
9. Mrs .Unnamalai 48 Female 12334 7.5.12 KMCH Diabetes NO NO Pseudomonas 9.2 11,000 P70,L27,E3 ,2,50,000 176 6.4 48 2.9 No Growth
Rt.Emphysematous
Pyelonephritis YES Rt. DJ Stenting NO NO
10. Mrs. Sumathi 49 Female 13213 12.5.12 KMCH Diabetes NO NO E.coli 10.4 17,600 P74,L23,E3 3,12,000 156 5.1 31 1.4 No Growth Lt. EmphysematousPyelonephritis NO Lt. Percutaneous Nephrostomy NO NO
11. Mrs.Kannagi 67 Female 997382 15.5.12 GRH Diabetes NO YES E.coli 8.6 9,800 P68,L30,E2 2,50,000 178 5.6 26 1.3 No Growth Lt. EmphysematousPyelonephritis NO
Lt. Percutaneous Nephrostomy
?
Lt.DJ Stenting
NO NO
12. Mrs.Parvathy 48 Female 13622 18.5.12 KMCH
Diabetes &
Urolithiasis YES NO Klebsiella 9.4 10,200 P63,L35,E2 76,000 257 9.3 60 2.9 E.coli Lt. Pyonephrosis YES Lt.  Percutaneous Nephrostomy YES NO
13. Mrs.Jothi 50 Female 998998 25.5.12 GRH
Diabetes &
Urolithiasis NO NO Proteus 9.5 9,500 P65,L34,E1 80,000 211 6.7 45 2.7 No Growth
Rt. Perinephric
Abscess NO Open Drainage YES NO
14. Ms.Santhya 24 TransGender 15786 4.6.12 KMCH Lower Urinary Tract Obstruction NO YES E.coli 8.7 19,800 P80,L19,E1 1,78,000 123 - 55 2.6 No Growth
Rt.Perinephric
Abscess NO Open Drainage NO NO
15. Mr.Mohan 50 Male 16824 13.6.12 KMCH Diabetes NO NO No Growth 12 8,900 P65,L34,E1 2,30,000 110 5.2 26 1.2 No Growth Lt. Renal CorticalAbscess NO Medical Management NO NO
16. Mr.Murugan 28 Male 100927 20.6.12 GRH PUJ Obstruction NO NO No Growth 11.5 16,500 P72,L36,E2 73,000 114 - 49 2.7 No Growth Rt.Pyonephrosis YES Rt.  Percutaneous Nephrostomy YES NO
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17. Mr.Sankar 40 Male 101834 4.7.12 GRH
Diabetes &
Urolithiasis NO NO E.coli 10.2 17,000 P73,L25,E2 1,78,000 230 7.8 32 1.6 No Growth
Lt. Emphysematous
Pyelonephritis NO Lt.DJ Stenting NO NO
18. Mrs.Prabhavathi 45 Female 101654 13.7.12 GRH Diabetes &Urolithiasis YES NO No Growth 9.3 15,500 P78,L21,E1 2,50,000 209 8.4 59 2.8 No Growth Lt. Pyonephrosis YES Lt.  Percutaneous Nephrostomy YES NO
19. Mrs.Parameswari 67 Female 25293 7.8.12 KMCH Diabetes YES YES Klebsiella 9.6 8,900 P70,L28,E2 80,000 289 11.2 60 3.1 Pseudomonas Lt. EmphysematousPyelonephritis YES Lt.  Percutaneous Nephrostomy YES NO
20. Mrs.Pencillama 56 Female 105192 13.8.12 GRH Diabetes NO NO No Growth 11.3 7,900 P67,L32,E1 2,30,000 156 5.1 28 1.3 No Growth Rt.Renal CorticalAbscess NO USG guided Aspiration NO NO
21. Ms. Lakshmi 22 Female 105212 22.8.12 GRH Diabetes &Urolithiasis NO NO E.coli 11.2 16,500 P72,L26,E2 3,10,000 145 5.7 52 2.7 Staphylococcus Lt. Pyonephrosis YES Lt.  Percutaneous Nephrostomy NO NO
22. Mr.Thangadurai 39 Male 105894 24.8.12 GRH Diabetes &Urolithiasis YES YES No Growth 10.2 7,900 P68,L30,E2 87,000 267 8.5 50 3.1 No Growth Rt. Pyonephrosis YES Rt.  Percutaneous Nephrostomy YES NO
23. Mrs. Muthamil 63 Female 106254 13.9.12 GRH Diabetes NO NO Klebsiella 11 18,700 P75,L24,E1 2,10,000 178 6.4 39 2.6 No Growth Lt. EmphysematousPyelonephritis NO
Lt. Percutaneous Nephrostomy
?
Lt.DJ Stenting
NO NO
24. Mrs. Mydeen Meeral 53 Female 107694 17.9.12 GRH Diabetes NO NO Citrobacter 9.8 15,600 P78,L21,E1 3,19,000 165 6.1 30 1.5 No Growth
Rt.
Emphysematous
Pyelonephritis
NO Rt. DJ Stenting NO NO
25. Mr.Subramani 50 Male 28436 29.9.12 KMCH NeurogenicDysfunction NO YES No Growth 10.2 10,800 P70,L29,E1 73,000 112 - 57 2.7 No Growth Rt. Pyonephrosis YES Rt.  Percutaneous Nephrostomy YES NO
26. Mrs. Vasanthi 67 Female 31334 7.10.12 KMCH Diabetes NO NO E.coli 10.3 9,600 P69,L30,E1 67,000 332 9.5 60 2.9 E.coli Lt. EmphysematousPyonephrosis YES
Lt. Percutaneous Nephrostomy
?
Lt.DJ Stenting
YES YES
27. Mrs.Anthoniammal 47 Female 32374 5.11.12 KMCH Diabetes &Urolithiasis YES YES E.coli 8.3 11,700 P66,L32,E2 84,000 275 8.3 47 2.6 Staphylococcus Rt. Pyonephrosis YES Rt.  Percutaneous Nephrostomy YES YES
28. Mr. Abdul Kani 23 Male 113045 9.12.12 GRH Urolithiasis NO NO E.coli 12.2 16,800 P72,L27,E1 2,75,000 98 - 65 3.1 No Growth Rt.Pyonephrosis YES Rt.  Percutaneous Nephrostomy YES NO
29. Mrs. Radha 30 Female 113302 17.12.12 GRH Diabetes &Urolithiasis YES YES No Growth 10.3 19,200 P81,L17,E1 91,000 234 7.8 72 2.8 Klebsiella Lt. Pyonephrosis YES Lt.   Percutaneous Nephrostomy YES NO
30. Mrs. Vatchala 47 Female 113937 26.12.12 GRH Diabetes NO NO E.coli 11 15,500 P72,L26,E2 1,87,000 254 7.3 64 2.9 No Growth
Rt.
Emphysematous
Pyelonephritis
NO Rt. DJ Stenting NO NO
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ANNEXURE VI – TURNITIN REPORT FOR PLAGIARISM
